Sun Pharmaceutical Industries Share Price Today - Live Blog for September 03, 2025

Sun Pharmaceutical Industries Ltd's shares experienced a 0.10% uptick, and they are currently valued at ₹1,580.65, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.10% increase in its share price and is currently trading at ₹1,580.65. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.27% increase in its share price and is currently trading at ₹1,577.15. This remarkable performance has caught the eye of investors.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.11% decline and is currently trading at ₹1,573.95 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

After a -0.05% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,576.25. The stock has a PE ratio of 36.1900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.01% decline and is currently trading at ₹1,577.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd shares saw a -0.09% decrease, reaching a current market price of ₹1,576.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 36.1900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.34%, reaching the current market value of ₹1,577.55 per share. This surge is a testament to the stock's recent performance.

With a -0.07% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,571.35. Investors should examine the factors driving this decline. The stock's PE ratio is 36.1900, whereas the industry PE ratio stands at 34.3513.

With a -0.02% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,572.50. The stock is currently trading at a PE of 36.1900, while the industry PE is 34.3513, prompting investors to assess its value proposition.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.03%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,572.10, but investors are assessing whether this is a temporary dip or a long-term trend.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.00% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,572.60 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.11%. At this moment, it's actively trading at ₹1,572.95, presenting an enticing opportunity for those in the market.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.04% recently. As of now, this stock is actively trading at a current market price of ₹1,571.30 per share, attracting attention from investors.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.04% gain, with the share price now at ₹1,571.30. Notably, the stock's PE ratio stands at 36.1900, and its Return on Equity (ROE) is 15.1334%.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.27% decline, and it currently trades at ₹1,569.35 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.01% decline, and it currently trades at ₹1,572.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.17% drop, and it's now trading at ₹1,572.15 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.23%, reaching the current market price of ₹1,574.80. This development underscores the stock's growing popularity.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.25% recently. As of now, this stock is actively trading at a current market price of ₹1,570.80 per share, attracting attention from investors.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.04% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,566.90, making it an appealing option for investors.

Sun Pharmaceutical Industries Ltd shares saw a -0.26% decrease, reaching a current market price of ₹1,565.25. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 36.1900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.20%, a situation worth noting. At present, the stock is trading at ₹1,570.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 36.1900, while the industry PE ratio is 34.3513.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.40% gain, with the share price now at ₹1,573.20. Notably, the stock's PE ratio stands at 36.1900, and its Return on Equity (ROE) is 15.1334%.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.07% increase. Presently, it is actively trading at ₹1,566.50.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.30% surge in its share price and is presently trading at ₹1,565.20, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd experienced a -0.59% downturn in its share price, and it's currently trading at ₹1,560.50. This situation is generating interest among value investors who are evaluating the stock's potential.